Appili Therapeutics Inc Cash Flow-to-Debt Ratio
Appili Therapeutics Inc cash flow-to-debt ratio. Appili Therapeutics Inc (APLI) has a Cash Flow-to-Debt Ratio of -0.02x as of December 2025, meaning its operating cash flow of CA$-293.07K could theoretically repay 0% of its total liabilities (CA$16.93 Million) in one year. Check Appili Therapeutics Inc (APLI) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Appili Therapeutics Inc (2017–2025)
Cash flow-to-debt ratio of Appili Therapeutics Inc from 2017 to 2025. Historical debt coverage capacity for Appili Therapeutics Inc across 9 annual periods. Check Appili Therapeutics Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Appili Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2017–2025)
Appili Therapeutics Inc cash flow-to-debt ratio by year from 2017 to 2025. Year-by-year debt coverage analysis for Appili Therapeutics Inc. For the full cash flow conversion analysis, see APLI operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.05x | CA$868.82K | CA$16.43 Million | ▲ +126.6% |
| 2024 | -0.20x | CA$-2.46 Million | CA$12.42 Million | ▲ +79.3% |
| 2023 | -0.96x | CA$-10.10 Million | CA$10.53 Million | ▲ +41.9% |
| 2022 | -1.65x | CA$-19.08 Million | CA$11.55 Million | ▲ +19.7% |
| 2021 | -2.06x | CA$-11.45 Million | CA$5.56 Million | ▼ -12.5% |
| 2020 | -1.83x | CA$-4.26 Million | CA$2.33 Million | ▼ -27.8% |
| 2019 | -1.43x | CA$-3.46 Million | CA$2.42 Million | ▼ -0.7% |
| 2018 | -1.42x | CA$-3.30 Million | CA$2.32 Million | ▲ +20.6% |
| 2017 | -1.79x | CA$-2.14 Million | CA$1.19 Million | — |